Hypothyroidism

Reduced Hormone Supply in Pregnant Mothers Linked to ADHD in Their Children

Retrieved on: 
수요일, 10월 21, 2020

The authors say their findings also show that boys born to hypothyroid women were four times more vulnerable to ADHD than girls whose mothers had hypothyroidism.

Key Points: 
  • The authors say their findings also show that boys born to hypothyroid women were four times more vulnerable to ADHD than girls whose mothers had hypothyroidism.
  • Hispanic children born to hypothyroid mothers had the highest risk of any ethnic group studied.
  • Hispanic children whose mothers had low thyroid hormone levels during pregnancy had a 45 percent increased risk for the neurodevelopmental disorder compared with a 22 percent increased risk in white children whose mothers had the same condition.
  • Peltier says his team's results are strong enough to warrant careful monitoring of pregnant women with low thyroid hormone levels.

Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency

Retrieved on: 
금요일, 9월 18, 2020

ATLANTA, Sept. 18, 2020 /PRNewswire/ -- Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level.

Key Points: 
  • ATLANTA, Sept. 18, 2020 /PRNewswire/ -- Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level.
  • The products are being recalled because testing has found these lots to be sub potent.
  • To date, Acella has received four reports of adverse events for these lot numbers possibly related to this recall.
  • NP Thyroid, Thyroid Tablets, USP is composed of levothyroxine and liothyronine, and used to treat hypothyroidism (underactive thyroid).

Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency

Retrieved on: 
금요일, 5월 22, 2020

ATLANTA, May 22, 2020 /PRNewswire/ --Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid (thyroid tablets, USP) to the consumer level.

Key Points: 
  • ATLANTA, May 22, 2020 /PRNewswire/ --Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid (thyroid tablets, USP) to the consumer level.
  • The products are being recalled because our testing has found these lots to be superpotent.
  • Pregnant women who take superpotent NP Thyroid may also experience negative maternal and fetal outcomes including miscarriage and/or impairment to fetal development.
  • NP Thyroid (thyroid tablets, USP) is composed of levothyroxine and liothyronine, and used to treat hypothyroidism (underactive thyroid).

PROGENICS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS

Retrieved on: 
금요일, 3월 13, 2020

Evaluate for clinical evidence of hypothyroidism and measure thyroid-stimulating hormone (TSH) levels prior to initiating AZEDRA and annually thereafter.

Key Points: 
  • Evaluate for clinical evidence of hypothyroidism and measure thyroid-stimulating hormone (TSH) levels prior to initiating AZEDRA and annually thereafter.
  • To report suspected adverse reactions, contact Progenics Pharmaceuticals, Inc. at 844-668-3950 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .
  • Such statements are predictions only and are subject to risks and uncertainties that could cause actual events or results to differ materially.
  • Additional information concerning Progenics and its business may be available in press releases or other public announcements and public filings made after this press release.

Screening for thyroid dysfunction in patients without symptoms: don't routinely check that box

Retrieved on: 
월요일, 11월 18, 2019

Based on the latest evidence, the Task Force guideline recommends against routine screening for thyroid dysfunction in non pregnant adults and is published in CMAJ (Canadian Medical Association Journal).

Key Points: 
  • Based on the latest evidence, the Task Force guideline recommends against routine screening for thyroid dysfunction in non pregnant adults and is published in CMAJ (Canadian Medical Association Journal).
  • Routine screening for thyroid dysfunction in people without symptoms or risk factors is commonly ordered, but practice varies by primary care practitioner.
  • When done, blood tests are ordered by checking the box on a requisition - to measure Thyroid Stimulating Hormone (TSH) levels which may indicate an underactive (hypothyroidism) or overactive thyroid gland (hyperthyroidism).
  • "Recommendations on screening adults for asymptomatic thyroid dysfunction in primary care" is published November 18, 2019

Morris Animal Foundation-Funded Researchers Find Omega-3 Fatty Acid Supplements And Hypothyroidism Both Linked To Decreased Risk Of T-Zone Lymphoma In Dogs

Retrieved on: 
수요일, 4월 3, 2019

DENVER, April 3, 2019 /PRNewswire/ -- Dogs that receive omega-3 fatty acid supplements or have hypothyroidism may be less likely to develop T-zone lymphoma (TZL).

Key Points: 
  • DENVER, April 3, 2019 /PRNewswire/ -- Dogs that receive omega-3 fatty acid supplements or have hypothyroidism may be less likely to develop T-zone lymphoma (TZL).
  • Those are two findings from Morris Animal Foundation-funded researchers at Colorado State University , who studied associations of environment and health history of the disease among golden retrievers.
  • "We were also a little surprised to discover that defective genes that lead to another, seemingly unrelated disorder hypothyroidism are more common in dogs that do not develop T-zone lymphoma."
  • Researchers recruited dogs from Morris Animal Foundation's Canine Lifetime Health Project, a registry of dogs whose owners are interested in participating in clinical trials and other studies to improve canine health.

Tirosint®-SOL Now Available to Treat Hypothyroidism in the U.S.

Retrieved on: 
수요일, 2월 27, 2019

Tirosint-SOL is the first and only liquid levothyroxine formulation approved by the FDA and is indicated for patients of all ages.

Key Points: 
  • Tirosint-SOL is the first and only liquid levothyroxine formulation approved by the FDA and is indicated for patients of all ages.
  • It is used to treat patients who suffer from hypothyroidism or inadequate levels of thyroid stimulating hormone (TSH).
  • It will be available through participating mail order and retail pharmacies starting March 1st, " stated Aldo Donati, CEO of IBSA Pharma.
  • For patients without insurance or with high copays or deductibles, the Tirosint Direct Program is available through participating mail order pharmacies and offers the lowest cash price available.

Steps to Help Keep Pets Healthy as Part of New Year's Resolutions

Retrieved on: 
금요일, 12월 28, 2018

While overfeeding is a common cause of pets gaining weight, other factors such as endocrine disorders may affect your pet's metabolism, including hypothyroidism or hyperadrenocorticism (Cushing's Syndrome).

Key Points: 
  • While overfeeding is a common cause of pets gaining weight, other factors such as endocrine disorders may affect your pet's metabolism, including hypothyroidism or hyperadrenocorticism (Cushing's Syndrome).
  • Your veterinarian can assess your pet's ideal weight, caloric needs, and any contributing health issues.
  • "Just a few simple steps can help support a pet's wellbeing in 2019, such as keeping them at a healthy weight and providing a complete and balanced diet."
  • Specific steps for unique challenges include:
    For the treat hound: Treats should be kept to no more than 10 percent of your pet's daily calories.